Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Cioffi

Showing results (121-130 of 146) with videos related to

Pageof 15
Sort By:
Giornale Italiano Di Cardiologia (2006)|July 10, 2015
[Nonvalvular atrial fibrillation: data from the Observatory of Cardiovascular Diseases in the province of Trieste (Italy)]Carmine Mazzone, Cosimo Carriere, Eliana Grande, et al.
International Journal of Cardiology|December 16, 2014
Reasons why patients suffering from chronic heart failure at very high risk for death surviveGiovanni Cioffi, Giovanni Pulignano, Giulia Barbati, et al.
European Journal of Preventive Cardiology|July 30, 2011
Analysis of midwall shortening reveals high prevalence of left ventricular myocardial dysfunction in patients with diabetes mellitus: the DYDA studyGiovanni Cioffi, Carlo B Giorda, Marcello Chinali, et al.
European Journal of Heart Failure|September 19, 2018
Is mild asymptomatic left ventricular systolic dysfunction always predictive of adverse events in high-risk populations? Insights from the DAVID-Berg studyMauro Gori, Margaret M Redfield, Alice Calabrese, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|April 1, 2011
Predictors of early-stage left ventricular dysfunction in type 2 diabetes: results of DYDA studyCarlo B Giorda, Giovanni Cioffi, Giovanni de Simone, et al.
The Oncologist|June 8, 2012
Administration of angiotensin-converting enzyme inhibitors and β-blockers during adjuvant trastuzumab chemotherapy for nonmetastatic breast cancer: marker of risk or cardioprotection in the real world?Stefano Oliva, Giovanni Cioffi, Silvia Frattini, et al.
Internal and Emergency Medicine|May 6, 2011
Prevalence and prognostic role of anaemia in patients with acute heart failure and preserved or depressed ventricular functionLuigi Tarantini, Fabrizio Oliva, Silvia Cantoni, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|February 20, 2016
Atrial fibrillation, cognitive impairment, frailty and disability in older heart failure patientsGiovanni Pulignano, Donatella Del Sindaco, Maria D Tinti, et al.
Echocardiography (Mount Kisco, N.Y.)|November 6, 2014
Combined circumferential and longitudinal left ventricular systolic dysfunction in patients with asymptomatic aortic stenosisGiovanni Cioffi, Carmine Mazzone, Giulia Barbati, et al.
Diabetes Research and Clinical Practice|June 29, 2013
Left ventricular dysfunction and outcome at two-year follow-up in patients with type 2 diabetes: The DYDA studyGiovanni Cioffi, Pompilio Faggiano, Donata Lucci, et al.
Pageof 15

Showing results (121-130 of 146) with videos related to

Sort By:
Pageof 15
Giornale Italiano Di Cardiologia (2006)|July 10, 2015
[Nonvalvular atrial fibrillation: data from the Observatory of Cardiovascular Diseases in the province of Trieste (Italy)]Carmine Mazzone, Cosimo Carriere, Eliana Grande, et al.
International Journal of Cardiology|December 16, 2014
Reasons why patients suffering from chronic heart failure at very high risk for death surviveGiovanni Cioffi, Giovanni Pulignano, Giulia Barbati, et al.
European Journal of Preventive Cardiology|July 30, 2011
Analysis of midwall shortening reveals high prevalence of left ventricular myocardial dysfunction in patients with diabetes mellitus: the DYDA studyGiovanni Cioffi, Carlo B Giorda, Marcello Chinali, et al.
European Journal of Heart Failure|September 19, 2018
Is mild asymptomatic left ventricular systolic dysfunction always predictive of adverse events in high-risk populations? Insights from the DAVID-Berg studyMauro Gori, Margaret M Redfield, Alice Calabrese, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|April 1, 2011
Predictors of early-stage left ventricular dysfunction in type 2 diabetes: results of DYDA studyCarlo B Giorda, Giovanni Cioffi, Giovanni de Simone, et al.
The Oncologist|June 8, 2012
Administration of angiotensin-converting enzyme inhibitors and β-blockers during adjuvant trastuzumab chemotherapy for nonmetastatic breast cancer: marker of risk or cardioprotection in the real world?Stefano Oliva, Giovanni Cioffi, Silvia Frattini, et al.
Internal and Emergency Medicine|May 6, 2011
Prevalence and prognostic role of anaemia in patients with acute heart failure and preserved or depressed ventricular functionLuigi Tarantini, Fabrizio Oliva, Silvia Cantoni, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|February 20, 2016
Atrial fibrillation, cognitive impairment, frailty and disability in older heart failure patientsGiovanni Pulignano, Donatella Del Sindaco, Maria D Tinti, et al.
Echocardiography (Mount Kisco, N.Y.)|November 6, 2014
Combined circumferential and longitudinal left ventricular systolic dysfunction in patients with asymptomatic aortic stenosisGiovanni Cioffi, Carmine Mazzone, Giulia Barbati, et al.
Diabetes Research and Clinical Practice|June 29, 2013
Left ventricular dysfunction and outcome at two-year follow-up in patients with type 2 diabetes: The DYDA studyGiovanni Cioffi, Pompilio Faggiano, Donata Lucci, et al.
Pageof 15